NeoGenomics, Inc. P/E Ratio 2010–2025
NeoGenomics, Inc. reported 208.50 of price-to-earnings ratio for fiscal 2014. That was 130.4% higher than fiscal 2013. Compared with fiscal 2013, the change was +130.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | — | — |
| FY 2023 | — | — |
| FY 2022 | — | — |
| FY 2021 | — | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
| FY 2018 | — | — |
| FY 2017 | — | — |
| FY 2016 | — | — |
| FY 2015 | — | — |
| FY 2014 | 208.50 | +130.4% |
| FY 2013 | 90.50 | — |
| FY 2012 | — | — |
| FY 2011 | — | — |
| FY 2010 | — | — |
Source: NeoGenomics, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open NEO 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
NeoGenomics, Inc. reported 208.50 of price-to-earnings ratio for fiscal 2014. That was 130.4% higher than fiscal 2013. Compared with fiscal 2013, the change was +130.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for NeoGenomics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeoGenomics, Inc. — frequently asked questions
What is NeoGenomics, Inc.'s price-to-earnings ratio?
NeoGenomics, Inc. (NEO) reported price-to-earnings ratio of 208.50 for fiscal year 2014, per its SEC filings.
How has NeoGenomics, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2010 and 2025, NEO's price-to-earnings ratio grew at roughly 5.7% per year (compound annual rate), from 90.50 to 208.50.
Where does this data come from?
Figures are computed from NeoGenomics, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More NEO financial history
Full NEO fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →